Atlas Trials

Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer

Clinical trial NCT00601510 · COMPLETED

Trial details

NCT number
NCT00601510
Sponsor
Technical University of Munich
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2007-11-01
Primary completion
2011-01-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.